The outlook for Gland Pharma is bullish. The stock made a bullish breakout last week. Although the share price has declined on Monday, the breakout remains intact. Support is in the ₹1,850-₹1,845 region. Further dip from current levels can be limited to this support zone.

Video Credit: Businessline

Fresh buyers are likely to come into the market around the ₹1,850-₹1,845 region. Moving Average cross overs on the daily chart also strengthens the bullish case. Gland Pharma share price can rise to ₹2,100 in the next few weeks. Traders can go long now at ₹1,890. Accumulate on dips at ₹1,860. Keep the stop-loss at ₹1,770. Trail the stop-loss up to ₹1,940 as soon as the stock goes up to ₹1,980. Move the stop-loss further up to ₹2,010 when the share price touches ₹2,030. Exit the long positions at ₹2,080.

(Note: The recommendations are based on technical analysis. There is risk of loss in trading.)